Peritoneal carcinomatosis with urachal signet-cell adenocarcinoma

B. W. Loggie, R. A. Fleming, A. A. Hosseinian

Research output: Contribution to journalArticle

23 Scopus citations

Abstract

Urachal adenocarcinoma is an uncommon clinicopathologic entity associated with a dismal prognosis. We report a case of peritoneal carcinomatosis from urachal adenocarcinoma (signet cell type) treated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IPHC). Prior to treatment, disease had progressed with systemic chemotherapy. The patient remained free of symptomatic peritoneal disease or local recurrence but eventually died 25 months after IPHC and 31 months after diagnosis due to widespread bone metastases.

Original languageEnglish (US)
Pages (from-to)446-448
Number of pages3
JournalUrology
Volume50
Issue number3
DOIs
StatePublished - Sep 1 1997
Externally publishedYes

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Urology

Cite this